Amryt's Filsuvez succeeds in rare skin disease trial
Amryt Pharma said Filsuvez, its topical therapeutic gel, had demonstrated a significant increase in speed of wound healing in the rare disease Epidermolysis Bullosa (EB) in a late-stage trial.
Business
• 09 Sep 20
